| Application no. and date | 19728800.4 (espacenet) (Federated) (European Patent Register), 20190514 | | Patent/reg. no. and date | DK/EP 3794122, 20230809 | | Publication date | 20210324 | | Priority no. and date | US 201862671094 P, 20180514, US 201862727141 P, 20180905, US 201962816996 P, 20190312 | | EP pub. no. and date |
EP 3794122 20210324 | | Effective date | | | Applicant/owner | Alnylam Pharmaceuticals, Inc., 675 West Kendall Street
Henri A. Termeer Square
Cambridge, MA 02142, US | | Applicant ref. no. | ALNQ/P75463EP | | Inventor | HINKLE, Gregory, 300 Third Street ,3rd Floor
Cambridge, MA 02142, US,
FOSTER, Donald, 300 Third Street, 3rd Floor
Cambridge, MA 02142, US,
SCHLEGEL, Mark, K., 300 Third Street, 3rd Floor
Cambridge, MA 02142, US | | Representative | Potter Clarkson A/S, Regnbuepladsen 7, 1550 København V, DK | | Opponent | | | IPC Class | A61K 31/713 (2006.01) , A61P 9/00 (2006.01) , C12N 15/113 (2010.01) | | Title | ANGIOTENSINOGEN (AGT) IRNA COMPOSITIONS AND METHODS OF USE THEREOF | | Int. application no. | US2019032150 | | Int. publication no. | WO2019222166 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
